mTOR

  • The mechanistic target of Rapamycin (mTOR) is a ubiquitously-conserved serine/threonine kinase, which has a central function in integrating growth signals and orchestrating their physiologic effects on cellular level. mTOR is the core component of differently composed signaling complexes that differ in protein composition and molecular targets. Newly identified classes of mTOR inhibitors are being developed to block autoimmune diseases and transplant rejections but also to treat obesity, diabetes, and different types of cancer. Therefore, the selective and context-dependent inhibition of mTOR activity itself might come into the focus as molecular target to prevent severe diseases and possibly to extend life span. This review provides a general introduction to the molecular composition and physiologic function of mTOR complexes as part of the Special Issue “2018 Select Papers by \(\textit {Cells’}\) Editorial Board Members”.

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Fahd BoutoujaGND, Christian M. StiehmGND, Harald W. PlattaGND
URN:urn:nbn:de:hbz:294-67403
DOI:https://doi.org/10.3390/cells8010018
Parent Title (English):Cells
Subtitle (English):a cellular regulator interface in health and disease
Publisher:MDPI
Place of publication:Basel
Document Type:Article
Language:English
Date of Publication (online):2019/11/19
Date of first Publication:2019/01/02
Publishing Institution:Ruhr-Universität Bochum, Universitätsbibliothek
Tag:aging; autophagy; cancer; kinase; mTOR; phosphorylation
Volume:8
Issue:1
First Page:18-1
Last Page:18-23
Institutes/Facilities:Institut für Biochemie und Pathobiochemie, Abteilung für Systembiochemie, Arbeitsgruppe Biochemie Intrazellulärer Transportprozesse
open_access (DINI-Set):open_access
faculties:Medizinische Fakultät
Licence (English):License LogoCreative Commons - CC BY 4.0 - Attribution 4.0 International